Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Myocyte-derived Myomaker expression is required for regenerative fusion but exacerbates membrane instability in dystrophic myofibers
Michael J. Petrany, Taejeong Song, Sakthivel Sadayappan, Douglas P. Millay
Michael J. Petrany, Taejeong Song, Sakthivel Sadayappan, Douglas P. Millay
View: Text | PDF
Research Article Muscle biology Stem cells

Myocyte-derived Myomaker expression is required for regenerative fusion but exacerbates membrane instability in dystrophic myofibers

  • Text
  • PDF
Abstract

Muscle progenitor cell fusion is required for the formation and regeneration of multinucleated skeletal muscle fibers. Chronic muscle regeneration in Duchenne muscular dystrophy (DMD) is characterized by ongoing fusion of satellite cell (SC) progeny, but the effects of fusion on disease and the mechanisms by which fusion is accomplished in this setting are not fully understood. Using the mdx mouse model of DMD, we deleted the fusogenic protein Myomaker in SCs or myofibers. Following deletion in SCs, mice displayed a complete lack of myocyte fusion, resulting in severe muscle loss, enhanced fibrosis, and significant functional decline. Reduction of Myomaker in mature myofibers in mdx mice, however, led to minimal alterations in fusion dynamics. Unexpectedly, myofiber-specific deletion of Myomaker resulted in improvement of disease phenotype, with enhanced function and decreased muscle damage. Our data indicate that Myomaker has divergent effects on dystrophic disease severity depending upon its compartment of expression. These findings show that myocyte fusion is absolutely required for effective regeneration in DMD, but persistent Myomaker expression in myofibers due to ongoing fusion may have unintended deleterious consequences for muscle integrity. Thus, sustained activation of a component of the myogenic program in dystrophic myofibers exacerbates disease.

Authors

Michael J. Petrany, Taejeong Song, Sakthivel Sadayappan, Douglas P. Millay

×

Figure 4

Deletion of Myomaker in mature myofibers does not affect fusion dynamics in WT or mdx mice.

Options: View larger image (or click on image) Download as PowerPoint
Deletion of Myomaker in mature myofibers does not affect fusion dynamics...
(A) Schematic showing the mouse model and the timing of tamoxifen administration. (B) qPCR analysis from whole diaphragm muscle indicates reduced Myomaker expression in mdx MymkfiberKO mice (n = 5–7). (C) Quantification of centrally nucleated myofibers in tibialis anterior (TA) muscle revealed no change following deletion of Myomaker in myofibers (n = 4–7). (D) Fusion of BrdU+ nuclei is unaffected in mdx MymkfiberKO mice (n = 8–11). (E) Formation of de novo (Myh3+) myofibers is not significantly altered in mdx MymkfiberKO muscle (n = 8–11). (F) Schematic showing acute injury mouse model, timing of cardiotoxin injury, and tamoxifen regimen. (G) H&E stain of TA muscle 14 days postinjury. (H) Quantification of myofibers with central nuclei from laminin-stained sections (not shown) (n = 7). (I) Average cross-sectional area of TA myofibers was unchanged following Myomaker deletion in myofibers (n = 7). Statistical analysis and data presentation: (B) unpaired t test, *P < 0.05. Data are represented as mean ± SD. Scale bars: 50 μm (D and E), 100 μm (G).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts